New Biogen CEO: Honored to be successor at the helm of Biogen

CNBC's Meg Tirrell speaks to new Biogen CEO Michel Vounatsos about the outlook of the company, Eli Lilly's experimental Alzheimer's drug and his expectations of the Trump administration.